Nurix Therapeutics, Inc. (NRIX)
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies that modulate protein levels to treat cancer and other diseases. The company’s pipeline includes targeted protein degraders and inhibitors, aiming to address unmet medical needs in oncology and immunology. Nurix collaborates with leading pharmaceutical companies to advance its drug candidates through clinical development. Chart
Lumen Technologies, Inc. (LUMN)
Lumen Technologies, Inc., formerly known as CenturyLink, is a telecommunications company providing a range of services, including voice, data, and managed services, to residential and business customers. The company operates a global fiber network, delivering high-speed internet and connectivity solutions. Lumen focuses on enabling digital transformation for its clients through advanced networking and cloud services. Chart
Yatsen Holding Limited (YSG)
Yatsen Holding Limited is a Chinese beauty company known for its cosmetics and skincare brands, including Perfect Diary and Little Ondine. The company utilizes a direct-to-consumer model, leveraging e-commerce platforms and social media to reach a broad customer base. Yatsen emphasizes innovation and product development to cater to evolving consumer preferences in the beauty industry. Chart
Vera Therapeutics, Inc. (VERA)
Vera Therapeutics, Inc. is a clinical-stage biotechnology company developing treatments for immunological diseases. The company’s lead product candidate, atacicept, is being investigated for the treatment of IgA nephropathy, a kidney disorder. Vera focuses on advancing its pipeline through clinical trials to address unmet medical needs in autoimmune and inflammatory diseases. Chart